- Home
- IMNM vs HBNC Comparison
IMNM vs HBNC Comparison
Compare IMNM & HBNC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IMNM
- HBNC
- Stock Information
- Founded
- IMNM 2006
- HBNC 1873
- Country
- IMNM United States
- HBNC United States
- Employees
- IMNM N/A
- HBNC N/A
- Industry
- IMNM Medicinal Chemicals and Botanical Products
- HBNC Major Banks
- Sector
- IMNM Health Care
- HBNC Finance
- Exchange
- IMNM Nasdaq
- HBNC Nasdaq
- Market Cap
- IMNM 747.7M
- HBNC 809.8M
- IPO Year
- IMNM 2020
- HBNC N/A
- Fundamental
- Price
- IMNM $10.14
- HBNC $15.93
- Analyst Decision
- IMNM Strong Buy
- HBNC Hold
- Analyst Count
- IMNM 5
- HBNC 2
- Target Price
- IMNM $28.60
- HBNC $18.50
- AVG Volume (30 Days)
- IMNM 856.1K
- HBNC 160.7K
- Earning Date
- IMNM 11-13-2024
- HBNC 01-22-2025
- Dividend Yield
- IMNM N/A
- HBNC 3.98%
- EPS Growth
- IMNM N/A
- HBNC N/A
- EPS
- IMNM N/A
- HBNC 0.48
- Revenue
- IMNM $10,129,000.00
- HBNC $183,718,000.00
- Revenue This Year
- IMNM N/A
- HBNC N/A
- Revenue Next Year
- IMNM N/A
- HBNC $13.76
- P/E Ratio
- IMNM N/A
- HBNC $33.32
- Revenue Growth
- IMNM N/A
- HBNC N/A
- 52 Week Low
- IMNM $8.97
- HBNC $11.18
- 52 Week High
- IMNM $30.96
- HBNC $19.18
- Technical
- Relative Strength Index (RSI)
- IMNM 34.53
- HBNC 30.77
- Support Level
- IMNM $10.67
- HBNC $16.08
- Resistance Level
- IMNM $11.28
- HBNC $16.40
- Average True Range (ATR)
- IMNM 0.76
- HBNC 0.49
- MACD
- IMNM -0.27
- HBNC -0.18
- Stochastic Oscillator
- IMNM 0.63
- HBNC 0.00
About IMNM Immunome Inc.
Immunome Inc is a biopharmaceutical company. It is engaged in utilizing a proprietary human memory B cell platform to discover and develop first-in-class antibody therapeutics designed to change the way diseases are currently being treated. The objective of the company is to establish a broad pipeline of preclinical and clinical assets which itcan efficiently develop through successive value inflection points. The company's primary focus areas are oncology and infectious disease, including COVID-19. It operates in the U.S. Its current pipelines comprise IM-1021, a fibroblast activation protein (FAP) and and IM-4320.
About HBNC Horizon Bancorp Inc.
Horizon Bancorp (IN) is a United States-based holding company providing banking services. It is engaged in providing commercial and retail banking services, corporate and individual trust and agency services, and other services incident to banking. The company also provides commercial loans, real estate loans, mortgage warehouse loans, consumer loans, and other credit facilities. The company has one principal business segment, commercial banking.